|
One-Year Performance of Long-Term Catheters in Hemodialysis Patients
|
Sara Maghsoudlou1    , Saeed Amirkhanlou2 , Gholamreza Roshandel3 , Pezhman Kharazm * 4 |
1- General Physician, Golestan University of Medical Sciences, Gorgan, Iran.
2- Associate Professor of Nephrology, Clinical Research Development Unit (CRDU), Sayyad Shirazi Hospital, Department of Internal Medicine, School of Medicine, Golestan University of Medical Sciences, Gorgan, Iran.
3- Associate Professor of Epidemiology, Golestan Research Center of Gastroenterology and Hepatology (GRCGH), Golestan University of Medical Sciences, Gorgan, Iran.
4- Assistant Professor of Vascular Surgery, Clinical Research Development Unit (CRDU), 5th Azar Hospital, Department of Surgery, School of Medicine, Golestan University of Medical Sciences, Gorgan, Iran. , pezhmankh@goums.ac.ir |
|
|
Abstract: (1041 Views) |
Background and Objective: Ensuring suitable access to hemodialysis, which provides high-quality dialysis over an extended period, is a significant challenge for patients with End-Stage Renal Disease (ESRD). One crucial aspect of this is maintaining the performance of hemodialysis catheters. Our study, which aimed to evaluate the one-year performance of long-term catheters in chronic hemodialysis patients in Golestan Province, is a critical step toward improving patient care in this population.
Methods: This descriptive-analytical study was conducted on 99 patients (34 men and 65 women) with ESRD who were candidates for starting or continuing dialysis with a catheter in the educational and therapeutic centers of Golestan Province, Iran during 2021-22. Transjugular catheters were placed for the patients, and after one year, variables such as age, gender, history of diabetes, history of hypertension, catheter placement site (right or left jugular), and antiplatelet medication use were evaluated concerning the performance of long-term catheters in providing adequate flow for hemodialysis.
Results: In 91 patients (91.9%), the one-year catheter performance was assessed as satisfactory. The age of 61.6% of the patients were over 60 years old. Sixty-nine patients (69.7%) had a history of hypertension, and 58 patients (58.6%) had a history of diabetes. Fifty-seven patients (57.6%) received antiplatelet medication. The catheters were placed on the right side in 82 patients (82.8%). Catheter performance in patients taking antiplatelet medication was non-significantly higher than in those not taking antiplatelet medicines.
Conclusion: The performance of long-term catheters in chronic hemodialysis patients with ESRD showed no significant correlation with age, gender, diabetes, hypertension, antiplatelet medication use, or the side of the jugular vein where the catheter was placed. |
|
Keywords: End-Stage Kidney Disease [MeSH], Hemodialysis [MeSH], Catheters [MeSH]
Article ID: Vol26-13 |
|
|
Full-Text [PDF 588 kb]
(2678 Downloads)
| | Abstract (HTML) (124 Views)
|
|
Type of Study: Original Articles |
Subject:
Nephrology
|
|
|
|
|
|
|
| References |
1. Thurlow JS, Joshi M, Yan G, Norris KC, Agodoa LY, Yuan CM, et al. Global Epidemiology of End-Stage Kidney Disease and Disparities in Kidney Replacement Therapy. Am J Nephrol. 2021;52(2):98-107. doi: 10.1159/000514550. [ DOI] [ PubMed] 2. Lok CE, Huber TS, Lee T, Shenoy S, Yevzlin AS, Abreo K, et al. KDOQI Clinical Practice Guideline for Vascular Access: 2019 Update. Am J Kidney Dis. 2020 Apr;75(4 Suppl 2):S1-S164. doi: 10.1053/j.ajkd.2019.12.001. [ DOI] [ PubMed] 3. El Khudari H, Ozen M, Kowalczyk B, Bassuner J, Almehmi A. Hemodialysis Catheters: Update on Types, Outcomes, Designs and Complications. Semin Intervent Radiol. 2022 Feb;39(1):90-102. doi: 10.1055/s-0042-1742346. [ DOI] [ PubMed] 4. Boubes K, Shaikh A, Alsauskas Z, Dwyer A. New Directions in Ensuring Catheter Safety. Adv Chronic Kidney Dis. 2020 May;27(3):228-35. doi: 10.1053/j.ackd.2020.02.004. [ DOI] [ PubMed] 5. Yaxley J. Haemodialysis catheters - a review of design and function. Expert Rev Med Devices. 2022 Oct;19(10):757-62. doi: 10.1080/17434440.2022.2132148. [ DOI] [ PubMed] 6. Obialo CI, Conner AC, Lebon LF. Maintaining patency of tunneled hemodialysis catheters--efficacy of aspirin compared to warfarin. Scand J Urol Nephrol. 2003;37(2):172-76. doi: 10.1080/00365590310008938. [ DOI] [ PubMed] 7. Kumbar L, Yee J. Current Concepts in Hemodialysis Vascular Access Infections. Adv Chronic Kidney Dis. 2019 Jan;26(1):16-22. doi: 10.1053/j.ackd.2018.10.005. [ DOI] [ PubMed] 8. Braet P, Van Holsbeeck A, Buyck PJ, Laenen A, Claes K, De Vusser K, et al. Comparison of Clinical Performance Between Two Types of Symmetric-Tip Hemodialysis Catheters: A Single-Centre, Randomized Trial. Cardiovasc Intervent Radiol. 2023 Aug;46(8):983-90. doi: 10.1007/s00270-023-03476-0. [ DOI] [ PubMed] 9. Besarab A, Pandey R. Catheter management in hemodialysis patients: delivering adequate flow. Clin J Am Soc Nephrol. 2011 Jan;6(1):227-34. doi: 10.2215/CJN.04840610. [ DOI] [ PubMed] 10. Wilkieson TJ, Ingram AJ, Crowther MA, Soroka SD, Nagai R, Jindal KK, et al. Low-intensity adjusted-dose warfarin for the prevention of hemodialysis catheter failure: a randomized, controlled trial. Clin J Am Soc Nephrol. 2011 May;6(5):1018-24. doi: 10.2215/CJN.07240810. [ DOI] [ PubMed] 11. Chapla K, Oza-Gajera BP, Yevzlin AS, Shin JI, Astor BC, Chan MR. Hemodialysis catheter locking solutions and the prevention of catheter dysfunction: a meta-analysis. J Vasc Access. 2015 Mar-Apr;16(2):107-12. doi: 10.5301/jva.5000312. [ DOI] [ PubMed] 12. Suhocki PV, Conlon PJ Jr, Knelson MH, Harland R, Schwab SJ. Silastic cuffed catheters for hemodialysis vascular access: thrombolytic and mechanical correction of malfunction. Am J Kidney Dis. 1996 Sep;28(3):379-86. doi: 10.1016/s0272-6386(96)90495-3. [ DOI] [ PubMed] 13. Cheraghali R, Farshidmehr P. The Patency Rate of the Primary and Exchanged Femoral Haemodialysis Catheters. Malays J Med Sci. 2021 Aug;28(4):97-102. doi: 10.21315/mjms2021.28.4.10. [ DOI] [ PubMed] 14. Wójtowicz D, Cholewa D, Faba AM, Domańska B, Kokoszka J, Kopacz K, et al. Diabetes decreases patency of tunneled catheters in hemodialysis patients after first effective thrombolysis with urokinase. Ren Fail. 2018 Nov;40(1):384-89. doi: 10.1080/0886022X.2018.1487856. [ DOI] [ PubMed] 15. Budruddin M, Mohsin N, Amitabh J, Ehab M, Pramod K, Abbas P, et al. Femoral vein tunneled catheters as a last resort to vascular access: report of five cases and review of literature. Ren Fail. 2009;31(4):320-22. doi: 10.1080/08860220902780077. [ DOI] [ PubMed] 16. Brighton TA, Eikelboom JW, Mann K, Mister R, Gallus A, Ockelford P, et al. Low-dose aspirin for preventing recurrent venous thromboembolism. N Engl J Med. 2012 Nov;367(21):1979-87. doi: 10.1056/NEJMoa1210384. [ DOI] [ PubMed] 17. Coker MA, Black JR, Li Y, Varma R, Almehmi A, Abdel Aal AK, et al. An analysis of potential predictors of tunneled hemodialysis catheter infection or dysfunction. J Vasc Access. 2019 Jul;20(4):380-85. doi: 10.1177/1129729818809669. [ DOI] [ PubMed] 18. Xiong Y, Yu Y, Yang Y, Wang L, Shi P, Deng Y, et al. Impacts of age, diabetes, gender, and access type on costs associated with vascular access among Chinese patients on hemodialysis. Int J Artif Organs. 2021 May;44(5):302-309. doi: 10.1177/0391398820962112. [ DOI] [ PubMed] 19. Valliant AM, Chaudhry MK, Yevzlin AS, Astor B, Chan MR. Tunneled dialysis catheter exchange with fibrin sheath disruption is not associated with increased rate of bacteremia. J Vasc Access. 2015 Jan-Feb;16(1):52-56. doi: 10.5301/jva.5000301. [ DOI] [ PubMed] 20. Shi M, Cui T, Ma L, Zhou L, Fu P. Catheter Failure and Mortality in Hemodialysis Patients with Tunneled Cuffed Venous Catheters in a Single Center. Blood Purif. 2017;43(4):321-26. doi: 10.1159/000455062. [ DOI] [ PubMed] 21. Shingarev R, Barker-Finkel J, Allon M. Natural history of tunneled dialysis catheters placed for hemodialysis initiation. J Vasc Interv Radiol. 2013 Sep;24(9):1289-94. doi: 10.1016/j.jvir.2013.05.034. [ DOI] [ PubMed] 22. Palmer SC, Di Micco L, Razavian M, Craig JC, Ravani P, Perkovic V, et al. Antiplatelet therapy to prevent hemodialysis vascular access failure: systematic review and meta-analysis. Am J Kidney Dis. 2013 Jan;61(1):112-22. doi: 10.1053/j.ajkd.2012.08.031. [ DOI] [ PubMed] 23. Yang H, Chen F, Jiao H, Luo H, Yu Y, Hong HG, et al. Management of tunneled-cuffed catheter-related right atrial thrombosis in hemodialysis patients. J Vasc Surg. 2018 Nov;68(5):1491-98. doi: 10.1016/j.jvs.2018.02.039. [ DOI] [ PubMed] 24. Mozafar M, Samsami M, Sobhiyeh MR, Jabbehdari S, Fallah Zavareh M. Effectiveness of aspirin on double lumen permanent catheter efficacy in ESRD. Nephrourol Mon. 2013 Spring;5(2):762-65. doi: 10.5812/numonthly.8733. [ DOI] [ PubMed] 25. Weiss MF, Scivittaro V, Anderson JM. Oxidative stress and increased expression of growth factors in lesions of failed hemodialysis access. Am J Kidney Dis. 2001 May;37(5):970-80. doi: 10.1016/s0272-6386(05)80013-7. [ DOI] [ PubMed] 26. Fry AC, Stratton J, Farrington K, Mahna K, Selvakumar S, Thompson H, et al. Factors affecting long-term survival of tunnelled haemodialysis catheters--a prospective audit of 812 tunnelled catheters. Nephrol Dial Transplant. 2008 Jan;23(1):275-81. doi: 10.1093/ndt/gfm582. [ DOI] [ PubMed] 27. Engstrom BI, Horvath JJ, Stewart JK, Sydnor RH, Miller MJ, Smith TP, et al. Tunneled internal jugular hemodialysis catheters: impact of laterality and tip position on catheter dysfunction and infection rates. J Vasc Interv Radiol. 2013 Sep;24(9):1295-302. doi: 10.1016/j.jvir.2013.05.035. [ DOI] [ PubMed] |
|
| Send email to the article author |
|
|
|
|
